Literature DB >> 19093266

Lactoferrin and cancer disease prevention.

Lígia Rodrigues1, José Teixeira, Fernando Schmitt, Marie Paulsson, Helena Lindmark Månsson.   

Abstract

Lactoferrin (LF) is an iron-binding glycoprotein that is composed of the transferrin family and is predominantly found in the products of the exocrine glands located in the gateways of the digestive, respiratory, and reproductive systems, suggesting a role in the non-specific defence against invading pathogens. Additionally, several physiological roles have been attributed to LF, namely regulation of iron homeostasis, host defence against infection and inflammation, regulation of cellular growth, and differentiation and protection against cancer development and metastasis. These findings have suggested LF's great potential therapeutic use in cancer disease prevention and/or treatment, namely as a chemopreventive agent. This review looks at the recent advances in understanding the mechanisms underlying the multifunctional roles of LF and future perspectives on its potential therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19093266     DOI: 10.1080/10408390701856157

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  27 in total

1.  Does lactoferrin behave as an immunohistochemical oncofetal marker in bone and cartilage human neoplasms?

Authors:  Antonio Ieni; Valeria Barresi; Maddalena Grosso; Giuseppe Speciale; Michele A Rosa; Giovanni Tuccari
Journal:  Pathol Oncol Res       Date:  2010-10-24       Impact factor: 3.201

2.  Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9.

Authors:  Ying Zheng; Zailong Qin; Qiurong Ye; Pan Chen; Zhen Wang; Qun Yan; Zhaohui Luo; Xiaoping Liu; Yanhong Zhou; Wei Xiong; Jian Ma; Guiyuan Li
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

3.  Lactoferrin deficiency induces a pro-metastatic tumor microenvironment through recruiting myeloid-derived suppressor cells in mice.

Authors:  Lingyu Wei; Xuemei Zhang; Jia Wang; Qiurong Ye; Xiang Zheng; Qiu Peng; Ying Zheng; Peishan Liu; Xiaoyue Zhang; Zhengshuo Li; Can Liu; Qun Yan; Guiyuan Li; Jian Ma
Journal:  Oncogene       Date:  2019-08-28       Impact factor: 9.867

4.  Lactotransferrin expression is downregulated and affects the mitogen-activated protein kinase pathway in gastric cancer.

Authors:  Gengqiu Luo; Yanhong Zhou; Wei Yi; Hong Yi
Journal:  Oncol Lett       Date:  2015-03-03       Impact factor: 2.967

Review 5.  A Review of Potential Public Health Impacts Associated With the Global Dairy Sector.

Authors:  Leah Grout; Michael G Baker; Nigel French; Simon Hales
Journal:  Geohealth       Date:  2020-02-13

Review 6.  Human milk glycoproteins protect infants against human pathogens.

Authors:  Bo Liu; David S Newburg
Journal:  Breastfeed Med       Date:  2013-05-22       Impact factor: 1.817

7.  Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma.

Authors:  Wenling Zhang; Songqing Fan; Guoying Zou; Lei Shi; Zhaoyang Zeng; Jian Ma; Yanhong Zhou; Xiayu Li; Xinlin Zhang; Xiaoling Li; Ming Tan; Wei Xiong; Guiyuan Li
Journal:  Tumour Biol       Date:  2014-10-07

8.  Growth differentiation factor-15 and lactoferrin immuno-expression in breast cancer: relationship with body iron-status and survival outcome.

Authors:  Zheng Zhang; Hao-Jie Jiang; Huan-Huan Yang; Jin-Jin Ren; Guo-Qin Jiang; Jia-Ying Xu; Li-Qiang Qin
Journal:  Biometals       Date:  2021-01-23       Impact factor: 2.949

9.  Gene expression profiling of peripheral blood cells for early detection of breast cancer.

Authors:  Jørgen Aarøe; Torbjørn Lindahl; Vanessa Dumeaux; Solve Saebø; Derek Tobin; Nina Hagen; Per Skaane; Anders Lönneborg; Praveen Sharma; Anne-Lise Børresen-Dale
Journal:  Breast Cancer Res       Date:  2010-01-15       Impact factor: 6.466

10.  Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas.

Authors:  A Ieni; V Barresi; G Branca; G Giuffrè; M A Rosa; G Tuccari
Journal:  Oncol Lett       Date:  2013-03-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.